119 related articles for article (PubMed ID: 2952300)
21. Radioimmunoassay of neocarzinostatin, an antitumor protein.
Samy TS; Raso V
Cancer Res; 1976 Dec; 36(12):4378-81. PubMed ID: 63321
[TBL] [Abstract][Full Text] [Related]
22. Enzyme immunoassay of neocarzinostatin using beta-galactosidase as label.
Tanimori H; Kitagawa T; Tsunoda T; Tsuchiya R
J Pharmacobiodyn; 1981 Oct; 4(10):812-9. PubMed ID: 6459444
[TBL] [Abstract][Full Text] [Related]
23. [Neocarzinostatin: molecular mechanism of action and prospects for clinical use].
Köhnlein W; Jung G
Arzneimittelforschung; 1982; 32(11):1474-9. PubMed ID: 6217819
[TBL] [Abstract][Full Text] [Related]
24. Structure of the antitumor protein neocarzinostatin. Purification, amino acid composition, disulfide reduction, and isolation and composition of tryptic peptides.
Maeda H; Glaser CB; Czombos J; Meienhoffer J
Arch Biochem Biophys; 1974 Oct; 164(2):369-78. PubMed ID: 4282218
[No Abstract] [Full Text] [Related]
25. Role of epoxide in neocarzinostatin chromophore stability and action.
Lee SH; Goldberg IH
Mol Pharmacol; 1988 Apr; 33(4):396-401. PubMed ID: 2965788
[TBL] [Abstract][Full Text] [Related]
26. In vitro evolution of the binding specificity of neocarzinostatin, an enediyne-binding chromoprotein.
Heyd B; Pecorari F; Collinet B; Adjadj E; Desmadril M; Minard P
Biochemistry; 2003 May; 42(19):5674-83. PubMed ID: 12741824
[TBL] [Abstract][Full Text] [Related]
27. Binding of the nonprotein chromophore of neocarzinostatin to deoxyribonucleic acid.
Povirk LF; Goldberg IH
Biochemistry; 1980 Oct; 19(21):4773-80. PubMed ID: 6448634
[TBL] [Abstract][Full Text] [Related]
28. Stabilization of neocarzinostatin nonprotein chromophore activity by interaction with apoprotein and with HeLa cells.
Kappen LS; Goldberg IH
Biochemistry; 1980 Oct; 19(21):4786-90. PubMed ID: 6448635
[TBL] [Abstract][Full Text] [Related]
29. The acidic groups of the neocarzinostatin protein play an important role in its biological activity.
Schönlau F; Köhnlein W; Garnett MC
Mol Pharmacol; 1994 Jun; 45(6):1268-72. PubMed ID: 8022419
[TBL] [Abstract][Full Text] [Related]
30. A revised primary structure for neocarzinostatin based on fast atom bombardment and gas chromatographic-mass spectrometry.
Gibson BW; Herlihy WC; Samy TS; Hahm KS; Maeda H; Meienhofer J; Biemann K
J Biol Chem; 1984 Sep; 259(17):10801-6. PubMed ID: 6236220
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of neocarzinostatin (NCS).
Koide Y; Ito A; Ishii F; Koyama Y; Edo K; Ishida N
J Antibiot (Tokyo); 1982 Jun; 35(6):766-9. PubMed ID: 6214537
[No Abstract] [Full Text] [Related]
32. A facile method of purification of neocarzinostatin, an antitumor protein.
Samy TS; Hu JM; Meienhofer J; Lazarus H; Johnson RK
J Natl Cancer Inst; 1977 Jun; 58(6):1765-8. PubMed ID: 140942
[TBL] [Abstract][Full Text] [Related]
33. On the conformation of Phe78 of a chromoprotein antibiotic, neocarzinostatin.
Imajo S; Ishiguro M; Tanaka T; Hirama M; Teplyakov A
Bioorg Med Chem; 1995 Apr; 3(4):429-36. PubMed ID: 8581426
[TBL] [Abstract][Full Text] [Related]
34. Incorporation of 18O2 into thymidine 5'-aldehyde in neocarzinostatin chromophore-damaged DNA.
Chin DH; Carr SA; Goldberg IH
J Biol Chem; 1984 Aug; 259(16):9975-8. PubMed ID: 6236217
[TBL] [Abstract][Full Text] [Related]
35. Neocarzinostatin naphthoate synthase: an unique iterative type I PKS from neocarzinostatin producer Streptomyces carzinostaticus.
Sthapit B; Oh TJ; Lamichhane R; Liou K; Lee HC; Kim CG; Sohng JK
FEBS Lett; 2004 May; 566(1-3):201-6. PubMed ID: 15147895
[TBL] [Abstract][Full Text] [Related]
36. Reversible modification of arginine residues in neocarzinostatin. Isolation of a biologically active 89-residue fragment from the tryptic hydrolysate.
Samy TS; Kappen LS; Goldberg IH
J Biol Chem; 1980 Apr; 255(8):3420-6. PubMed ID: 6444949
[TBL] [Abstract][Full Text] [Related]
37. Three-dimensional solution structure of apo-neocarzinostatin.
Gao X
J Mol Biol; 1992 May; 225(1):125-35. PubMed ID: 1533878
[TBL] [Abstract][Full Text] [Related]
38. The inhibitory mechanism of in vitro protein phosphorylation by a nonprotein chromophore removed from neocarzinostatin.
Ohtsuki K; Sato T; Koike T; Koyama K; Ishida N
Biochim Biophys Acta; 1981 Mar; 673(2):147-56. PubMed ID: 6260230
[TBL] [Abstract][Full Text] [Related]
39. Hydrogen bromide adduct of neocarzinostatin chromophore: one of the stable derivatives of native neocarzinostatin chromophore.
Edo K; Akiyama-Murai Y; Saito K; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1988 Sep; 41(9):1272-4. PubMed ID: 2972669
[No Abstract] [Full Text] [Related]
40. Crystal structure of neocarzinostatin, an antitumor protein-chromophore complex.
Kim KH; Kwon BM; Myers AG; Rees DC
Science; 1993 Nov; 262(5136):1042-6. PubMed ID: 8235619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
